Kengreal (cangrelor) - Chiesi
REPERFUSE: REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (clinicaltrials.gov) - Mar 3, 2026 - P3 | N=368 | Recruiting | Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Trial completion date: Jan 2027 ➔ Sep 2030 | Trial primary completion date: Mar 2026 ➔ Mar 2030 
Trial completion date • Trial primary completion date • Cardiovascular
http://clinicaltrials.gov/ct2/show/NCT04667078
 
Mar 3, 2026
 
Prev Next